Market Brief: Risk off reduced with a drop in USD/CNH

A summary of the FX & stock market trends & highlights from today's Asian mid-session.

FX & Stock market snapshots as of [06/08/2019 0500 GMT]

  • The JPY crosses have continued to see heightened volatility where profit taking can be seen in yesterday’s USD/JPY shorts positions. The USD/JPY has rallied closed to 1.00% in today’s Asian session to retrace yesterday’s steep decline due to trade tensions escalation.
  • RBA has left the key policy cash rate unchanged at the lowest level of 1.00% as expected and admits that the Australian economy has slowed and cited renewed trade tensions between U.S. and China as a major concern. The AUD/USD has traded sideways below yesterday’s high of 0.6804.
  • Ahead of the European opening session, all Asian stock markets are still trading in the red with the Australia’s ASX 200 being the worst performer with a loss of -2.44% as at today’s Asian mid-session. Technology & Healthcare sectors are the biggest drag on the ASX 200 where both sectors have declined by -3.98% and -3.33% respectively.
  • After the U.S Treasury Dept has officially named China as a “currency manipulator”, the China central bank PBOC has guided the opening fixing on the onshore USD/CNY at 6.9683, above yesterday fixing of 6.9225 but below expectations of 6.9871.
  • The offshore USD/CNH has dropped by 807 pips from today’s Asian session high of 7.1400 to a current intraday low of 7.0593. A weakening USD/CNH has managed to trim earlier losses seen in the Asian stock markets.
  • The S&P E-mini futures has traded up by 2.91% from today’s Asian session low of 2775 to print a current intraday high of 2850.

Macroeconomic Calendar

*Data from Refinitiv. Index names may not reflect tradable instruments and not all markets are available in all regions.


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

StoneX Financial Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.